These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35321179)

  • 1. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
    Peng LP; Li J; Li XF
    World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.
    Tan S; Zheng Q; Zhang W; Zhou M; Xia C; Feng W
    Front Immunol; 2024; 15():1408700. PubMed ID: 39050856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.
    Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z
    Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis.
    Li LQ; Bai ZH; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Wen J; Li JZ
    Front Oncol; 2020; 10():30. PubMed ID: 32082998
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
    Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
    Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
    Peng H; Luo X
    Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
    Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
    Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
    Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
    Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
    Wang X; Su S; Guo Y
    Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis.
    Jiang Y; Xu D; Song H; Qiu B; Tian D; Li Z; Ji Y; Wang J
    BMJ Open; 2021 Sep; 11(9):e048324. PubMed ID: 34593492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis.
    Yang S; Zhao K; Ding X; Jiang H; Lu H
    J Cancer; 2019; 10(11):2568-2577. PubMed ID: 31258763
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
    Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
    Front Oncol; 2020; 10():178. PubMed ID: 32154173
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis.
    Wei ZW; Huang WB; Yang DJ; Yuan YJ; He YL; Zhang CH
    Transl Cancer Res; 2020 Sep; 9(9):5128-5138. PubMed ID: 35117879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas.
    Chen C; Chen G; Wu Y; Li J
    Transl Cancer Res; 2020 May; 9(5):3483-3490. PubMed ID: 35117713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis.
    Jiang M; Ma S; Hua Z; Zhao Z; Gao S
    Dis Markers; 2021; 2021():8839512. PubMed ID: 33897913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
    Matsas S; Aguiar PN; Del Giglio A
    J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.